[Cardiovascular effect of solcoseryl with low molecular dextran in normal late pregnancy].
By means of quantitative sphygmometry and the unbloody recording of arterial blood pressure the hemodynamic effect of an infusion of Solcoseryl in combination with low molecular dextrane on the maternal cardiovascular system in 9 normotensive healthy late pregnant women is examined. Solcoseryl causes no improvement of the cardiovascular effects known for low molecular dextrane.
D000183:Actihaemyl / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D003911:Dextrans / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D014020:Tissue Extracts / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects
D003911:Dextrans; D014020:Tissue Extracts; D000183:Actihaemyl
Die kardiovaskuläre Wirkung von Solcoseryl mit niedermolekularem Dextran in der normalen Spätschwangerschaft.